East Sussex - Better Together
NHS

6.7.1 Bromocriptine and other dopaminergic drugs

These drugs are indicated for the inhibition of prolactin release.  Refer to chapter 4.9 for their use in Parkinson's disease.

MHRA Safety Update: Ergot-derived dopamine agonists: risk of fibrotic reactions

Pack
8 tablet
  • First Line Drugs
  • Second Line Drugs
  • Specialist Initiated Drugs
  • Specialist Only Drugs
  • Mixed Status